Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HOLA: Out-of-Hospital LA Cabotegravir + Rilpivirine in HIV
NCT06185452Phase 4Completed
- Start
- Sep 2023
- Primary completion
- May 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cabotegravir, rilpivirine in human immunodeficiency virus type 1 infection (HIV-1). Started Sep 2023; status: completed.
02
Drugs
cabotegravirrilpivirine
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT06185452.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06185452.